AVE 25.0% 0.3¢ avecho biotechnology limited

18000 doses a day in anz, page-16

  1. 269 Posts.
    the projected half mill in revenue per year for Aus/NZ does not equate to 10 to 15c per share. More like 1c when you consider no. shares on issue likely to be over the billion mark when upcoming cap raising factored in.

    Appreciate your enthusiasm over the announcent but those figures are misleading.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.